SCHEMBL16813045

SCHEMBL16813045

CC1=C(c2cccnc2)c2[nH]c3ccc(Cl)cc3c2NC(=O)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.49
CDK5 Q00535 4/20 0.49
CDK5R1 Q15078 4/20 0.49
GSK3A P49840 3/20 0.49
CCNB2 O95067 3/20 0.47
CDK1 P06493 3/20 0.47
CCNB1 P14635 3/20 0.47
CCNB3 Q8WWL7 3/20 0.47
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 3/20 0.42
CYP1A2 P05177 2/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
CASP1 P29466 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PADI4 Q9UM07 1/20 0.39
CHUK O15111 1/20 0.38
TLR9 Q9NR96 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16813044 0.88 CDK5 (0.49) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL16813039 0.87 CDK5 (0.50) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL16796624 0.87 CYP11B1 (0.53) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL16812972 0.86 GSK3B (0.46) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL16813035 0.85 HPGD (0.47) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL16812975 0.80 GSK3B (0.45) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL1607053 0.75 CYP11B1 (0.69) CYP11B1CYP11B2CYP1A2KDM4EMEN1
SCHEMBL16812968 0.74 CDK5 (0.46) GSK3BCDK5CDK5R1GSK3ACCNB2
SCHEMBL16813043 0.74 IMPDH2 (0.46) GSK3BCDK5CDK5R1GSK3ACCNB2
Hydrochloric Acid SCHEMBL1605347 0.74 CYP11B1 (0.68) CYP11B1CYP11B2CYP1A2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015088565-A1 P2X4 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2015-06-18 WO disclosed